• HRC2018
  • 7 - 10 Oct 2018, The ICC, Birmingham UK
08:30 - 12:15 AF Association Improving AF Outcomes Outside the Lab Hall 9
08:30 - 12:15 Arrhythmia Alliance Improving care in patients at risk of sudden cardiac death Hall 11
08:30 - 10:00 Future perspectives of patient optimization in heart failure - Sponsored by Boston Scientific Hall 8b
08:30 - 12:15 Oral Abstracts 3 Hall 8a
10:45 - 12:15 The Zero Jargon Science Primer for Clinicians Hall 8b

Oral Abstracts 3 - Hall 8a - 08:30 - 12:15

AF Ablation
Chair: Mark O'Neill London UK
Chair: Arthur Yue Southampton UK
08:30 ABLATION OF LONGSTANDING PERSISTENT ATRIAL FIBRILLATION USING THE ACQMAP 3-D MAPPING SYSTEM – AN EARLY SINGLE CENTRE EXPERIENCE Ewen Shepherd Newcastle upon Tyne UK
08:45 IMPROVING TARGET IDENTIFICATION OF PERSISTENT ATRIAL FIBRILLATION ABLATION USING SIMULTANEOUS INTRACARDIAC MAPPING Xin Li Leicester UK
09:00 ACCURACY OF LEFT ATRIAL BIPOLAR VOLTAGES OBTAINED BY CONFIDENSE MULTIELECTRODE MAPPING IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Baptiste Maille Liverpool UK
09:15 THE IMPACT OF THE PRESENCE OF LEFT ATRIAL LOW VOLTAGE AREAS ON OUTCOMES FROM PULMONARY VEIN ISOLATION Fiyyaz Ahmed-Jushuf London UK
09:30 POWER, LESION SIZE INDEX AND OESOPHAGEAL TEMPERATURE ALERTS DURING ATRIAL FIBRILLATION ABLATION (PILOT-AF): A RANDOMIZED STUDY Milena Leo Oxford UK
09:45 Break
VT, EP & AF Ablation
10:45 EFFECT OF ACTIVATION WAVEFRONT ON ELECTROGRAM CHARACTERISTICS DURING VENTRICULAR TACHYCARDIA ABLATION Claire Martin Bordeaux FR
11:00 MULTIMODALITY IMAGE RECONSTRUCTION AND FUSION TO GUIDE VT ABLATION
11:15 APPLICATION OF THE NOVEL ‘SHANGHAI’ DIAGNOSTIC CRITERIA FOR BRUGADA SYNDROME REDUCES THE NUMBER OF DIAGNOSES WITH LOW RISK OF ARRHYTHMIC EVENTS IN INDEX CASES Greg Mellor Cambridge UK
11:30 DEVELOPMENT OF ATRIAL FIBRILLATION FOLLOWING ABLATION FOR TYPICAL ATRIAL FLUTTER CANNOT BE PREDICTED BY CONVENTIONAL RISK FACTORS; TIME FOR A RETHINK IN ABLATION STRATEGY? M Mann Liverpool UK
11:45 EVOLUTION OF PROMS DATA AND WHAT IT TELLS US ABOUT PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION J Girach Leicester UK
12:00 ATRIAL FIBRILLATION ABLATION AS A DAY-CASE PROCEDURE: THREE-YEAR SINGLE-CENTRE EXPERIENCE Stefano Bartoletti Liverpool UK
12:15 Close

Future perspectives of patient optimization in heart failure - Sponsored by Boston Scientific Future perspectives of patient optimization in heart failure - Sponsored by Boston Scientific - Hall 8b - 08:30 - 10:00

Chair: Martin Cowie London UK
08:30 How can we treat more CRT-indicated patients with better outcome? The clinical and economic impact of longevity Jay Wright Liverpool UK
08:50 The Multisense trial: finally a new perspective for monitoring patients with heart failure Roy Gardner Glasgow UK
09:10 A multiparametric approach to efficiently manage patients with Heart Failure: the HeartLogic philosophy Martin Cowie London UK
09:30 Can we save time and maximize outcome with Smart CRT Programming at implantation and follow-up? Alison Seed Blackpool UK
09:50 Discussion Martin Cowie London UK
10:00 Close

AF Association Improving AF Outcomes Outside the Lab AF Association Improving AF Outcomes Outside the Lab - Hall 9 - 08:30 - 12:15

Chair: Dhiraj Gupta Liverpool UK
Chair: Tim Betts Oxford UK
08:30 Is there such a thing as having too much choice? Which NOAC to choose for which patient? Irina Savelieva London UK
09:00 What constitutes a total contraindication to oral anticoagulation in the NOAC era? Who to refer on for Left Atrial Appendage Occlusion? Tim Betts Oxford UK
09:30 Heart Failure in AF: how important is rate control with Beta Blockers? Dipak Kotecha Birmingham UK
10:00 Break
Chair: Dhiraj Gupta Liverpool UK
Chair: Andre Ng Leicester UK
10:45 Mobile Apps and Devices: How have these impacted on AF detection and management? Andre Ng Leicester UK
11:15 Role of Biomarkers in stratifying stroke risk in AF; should the ABC score trump CHADSVASc score? Dipak Kotecha Birmingham UK
11:45 The relationship between AF burden and stroke risk: not what it seems? Derick Todd Liverpool UK
12:15 Close

Arrhythmia Alliance Improving care in patients at risk of sudden cardiac death Arrhythmia Alliance Improving care in patients at risk of sudden cardiac death - Hall 11 - 08:30 - 12:15

Chair: Pier Lambiase London UK
Chair: Kim Rajappan Oxford UK
08:30 Sudden death post MI: epidemiology and risk Andre Ng Leicester UK
09:00 The role of the nurse specialist in SCD treatment/prevention Craig Russell Leeds UK
09:30 Management of recurrent VT: drugs and ablation Prapa Kanagaratnam London UK
10:00 Break
10:45 ARVC: what's new in arrhythmia management Stephen Page Leeds UK
11:15 Cardiac sarcoidosis: managing risk of sudden cardiac death Kim Rajappan Oxford UK
11:45 The role of gene-based pharmacotherapy in preventing SCD - science fiction or reality? Pier Lambiase London UK
12:15 Close

The Zero Jargon Science Primer for Clinicians - Hall 8b - 10:45 - 12:15

Chair: Malcolm Finlay London UK
Chair: Gwilym Morris Manchester UK
10:45 Reintroducing the Cardiac Action Potential - Everything You Need to Know But Were Too Afraid To Ask Neil Herring Oxford UK
11:00 How Fat Gives You AF - and what YOU can do about it Fu Siong Ng London UK
11:30 Stresses and Strains : the brain, the heart and autonomic feedback Richard Ang London UK
11:45 Traffic Jams and arrhythmias : causes and cures from ion channel trafficking Stephen Harmer London UK
12:15 Close

Sign up to receive the latest updates